Table of Contents Chapter 1 Overview of Weight Loss Drugs 1.1 Definition of Weight Loss Drugs in This Report 1.2 Commercial Types of Weight Loss Drugs 1.2.1 Liauid 1.2.2 Tablets 1.3 Downstream Application of Weight Loss Drugs 1.3.1 Weight-reducing Aid 1.3.2 Other 1.4 Development History of Weight Loss Drugs 1.5 Market Status and Trend of Weight Loss Drugs 2013-2023 1.5.1 Global Weight Loss Drugs Market Status and Trend 2013-2023 1.5.2 Regional Weight Loss Drugs Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Weight Loss Drugs 2013-2017 2.2 Sales Market of Weight Loss Drugs by Regions 2.2.1 Sales Volume of Weight Loss Drugs by Regions 2.2.2 Sales Value of Weight Loss Drugs by Regions 2.3 Production Market of Weight Loss Drugs by Regions 2.4 Global Market Forecast of Weight Loss Drugs 2018-2023 2.4.1 Global Market Forecast of Weight Loss Drugs 2018-2023 2.4.2 Market Forecast of Weight Loss Drugs by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Weight Loss Drugs by Types 3.2 Sales Value of Weight Loss Drugs by Types 3.3 Market Forecast of Weight Loss Drugs by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Weight Loss Drugs by Downstream Industry 4.2 Global Market Forecast of Weight Loss Drugs by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Weight Loss Drugs Market Status by Countries 5.1.1 North America Weight Loss Drugs Sales by Countries (2013-2017) 5.1.2 North America Weight Loss Drugs Revenue by Countries (2013-2017) 5.1.3 United States Weight Loss Drugs Market Status (2013-2017) 5.1.4 Canada Weight Loss Drugs Market Status (2013-2017) 5.1.5 Mexico Weight Loss Drugs Market Status (2013-2017) 5.2 North America Weight Loss Drugs Market Status by Manufacturers 5.3 North America Weight Loss Drugs Market Status by Type (2013-2017) 5.3.1 North America Weight Loss Drugs Sales by Type (2013-2017) 5.3.2 North America Weight Loss Drugs Revenue by Type (2013-2017) 5.4 North America Weight Loss Drugs Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Weight Loss Drugs Market Status by Countries 6.1.1 Europe Weight Loss Drugs Sales by Countries (2013-2017) 6.1.2 Europe Weight Loss Drugs Revenue by Countries (2013-2017) 6.1.3 Germany Weight Loss Drugs Market Status (2013-2017) 6.1.4 UK Weight Loss Drugs Market Status (2013-2017) 6.1.5 France Weight Loss Drugs Market Status (2013-2017) 6.1.6 Italy Weight Loss Drugs Market Status (2013-2017) 6.1.7 Russia Weight Loss Drugs Market Status (2013-2017) 6.1.8 Spain Weight Loss Drugs Market Status (2013-2017) 6.1.9 Benelux Weight Loss Drugs Market Status (2013-2017) 6.2 Europe Weight Loss Drugs Market Status by Manufacturers 6.3 Europe Weight Loss Drugs Market Status by Type (2013-2017) 6.3.1 Europe Weight Loss Drugs Sales by Type (2013-2017) 6.3.2 Europe Weight Loss Drugs Revenue by Type (2013-2017) 6.4 Europe Weight Loss Drugs Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Weight Loss Drugs Market Status by Countries 7.1.1 Asia Pacific Weight Loss Drugs Sales by Countries (2013-2017) 7.1.2 Asia Pacific Weight Loss Drugs Revenue by Countries (2013-2017) 7.1.3 China Weight Loss Drugs Market Status (2013-2017) 7.1.4 Japan Weight Loss Drugs Market Status (2013-2017) 7.1.5 India Weight Loss Drugs Market Status (2013-2017) 7.1.6 Southeast Asia Weight Loss Drugs Market Status (2013-2017) 7.1.7 Australia Weight Loss Drugs Market Status (2013-2017) 7.2 Asia Pacific Weight Loss Drugs Market Status by Manufacturers 7.3 Asia Pacific Weight Loss Drugs Market Status by Type (2013-2017) 7.3.1 Asia Pacific Weight Loss Drugs Sales by Type (2013-2017) 7.3.2 Asia Pacific Weight Loss Drugs Revenue by Type (2013-2017) 7.4 Asia Pacific Weight Loss Drugs Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Weight Loss Drugs Market Status by Countries 8.1.1 Latin America Weight Loss Drugs Sales by Countries (2013-2017) 8.1.2 Latin America Weight Loss Drugs Revenue by Countries (2013-2017) 8.1.3 Brazil Weight Loss Drugs Market Status (2013-2017) 8.1.4 Argentina Weight Loss Drugs Market Status (2013-2017) 8.1.5 Colombia Weight Loss Drugs Market Status (2013-2017) 8.2 Latin America Weight Loss Drugs Market Status by Manufacturers 8.3 Latin America Weight Loss Drugs Market Status by Type (2013-2017) 8.3.1 Latin America Weight Loss Drugs Sales by Type (2013-2017) 8.3.2 Latin America Weight Loss Drugs Revenue by Type (2013-2017) 8.4 Latin America Weight Loss Drugs Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Weight Loss Drugs Market Status by Countries 9.1.1 Middle East and Africa Weight Loss Drugs Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Weight Loss Drugs Revenue by Countries (2013-2017) 9.1.3 Middle East Weight Loss Drugs Market Status (2013-2017) 9.1.4 Africa Weight Loss Drugs Market Status (2013-2017) 9.2 Middle East and Africa Weight Loss Drugs Market Status by Manufacturers 9.3 Middle East and Africa Weight Loss Drugs Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Weight Loss Drugs Sales by Type (2013-2017) 9.3.2 Middle East and Africa Weight Loss Drugs Revenue by Type (2013-2017) 9.4 Middle East and Africa Weight Loss Drugs Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Weight Loss Drugs 10.1 Global Economy Situation and Trend Overview 10.2 Weight Loss Drugs Downstream Industry Situation and Trend Overview Chapter 11 Weight Loss Drugs Market Competition Status by Major Manufacturers 11.1 Production Volume of Weight Loss Drugs by Major Manufacturers 11.2 Production Value of Weight Loss Drugs by Major Manufacturers 11.3 Basic Information of Weight Loss Drugs by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Weight Loss Drugs Major Manufacturer 11.3.2 Employees and Revenue Level of Weight Loss Drugs Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Weight Loss Drugs Major Manufacturers Introduction and Market Data 12.1 Roche 12.1.1 Company profile 12.1.2 Representative Weight Loss Drugs Product 12.1.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Roche 12.2 GSK group 12.2.1 Company profile 12.2.2 Representative Weight Loss Drugs Product 12.2.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of GSK group 12.3 Teva 12.3.1 Company profile 12.3.2 Representative Weight Loss Drugs Product 12.3.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Teva 12.4 Sandoz(Novartis) 12.4.1 Company profile 12.4.2 Representative Weight Loss Drugs Product 12.4.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Sandoz(Novartis) 12.5 STADA-VN J.V.Co., Ltd 12.5.1 Company profile 12.5.2 Representative Weight Loss Drugs Product 12.5.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of STADA-VN J.V.Co., Ltd 12.6 Hexal AG 12.6.1 Company profile 12.6.2 Representative Weight Loss Drugs Product 12.6.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hexal AG 12.7 National Company For Pharmaceutical Industry 12.7.1 Company profile 12.7.2 Representative Weight Loss Drugs Product 12.7.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of National Company For Pharmaceutical Industry 12.8 Lunan Pharmaceutical Group Corporation 12.8.1 Company profile 12.8.2 Representative Weight Loss Drugs Product 12.8.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Lunan Pharmaceutical Group Corporation 12.9 Zein Pharmaceutical 12.9.1 Company profile 12.9.2 Representative Weight Loss Drugs Product 12.9.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Zein Pharmaceutical 12.10 Hisun 12.10.1 Company profile 12.10.2 Representative Weight Loss Drugs Product 12.10.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hisun 12.11 Taj Pharmaceuticals Ltd 12.11.1 Company profile 12.11.2 Representative Weight Loss Drugs Product 12.11.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Ltd 12.12 Kabir Life Sciences & Research 12.12.1 Company profile 12.12.2 Representative Weight Loss Drugs Product 12.12.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Kabir Life Sciences & Research 12.13 Dm Pharma 12.13.1 Company profile 12.13.2 Representative Weight Loss Drugs Product 12.13.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Dm Pharma 12.14 China Zhongshan Pharm 12.14.1 Company profile 12.14.2 Representative Weight Loss Drugs Product 12.14.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of China Zhongshan Pharm Chapter 13 Upstream and Downstream Market Analysis of Weight Loss Drugs 13.1 Industry Chain of Weight Loss Drugs 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Weight Loss Drugs 14.1 Cost Structure Analysis of Weight Loss Drugs 14.2 Raw Materials Cost Analysis of Weight Loss Drugs 14.3 Labor Cost Analysis of Weight Loss Drugs 14.4 Manufacturing Expenses Analysis of Weight Loss Drugs Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Liauid Table Advantage and Disadvantage of Tablets Table Sales Volume of Weight Loss Drugs by Regions 2013-2017 Table Sales Value of Weight Loss Drugs by Regions 2013-2017 Table Production Volume of Weight Loss Drugs by Regions 2013-2017 Table Global Sales Volume of Weight Loss Drugs by Regions 2018-2023 Table Global Sales Value of Weight Loss Drugs by Regions 2018-2023 Table Global Production Volume of Weight Loss Drugs by Regions 2018-2023 Table Sales Volume of Weight Loss Drugs by Types 2013-2017 Table Sales Value of Weight Loss Drugs by Types 2013-2017 Table Sales Volume Forecast of Weight Loss Drugs by Types 2018-2023 Table Sales Value Forecast of Weight Loss Drugs by Types 2018-2023 Table Sales Volume of Weight Loss Drugs by Downstream Industry 2013-2017 Table Sales Volume Forecast of Weight Loss Drugs by Downstream Industry 2018-2023 Table North America Weight Loss Drugs Sales by Countries (2013-2017) Table North America Weight Loss Drugs Sales Share by Countries (2013-2017) Table North America Weight Loss Drugs Revenue by Countries (2013-2017) Table North America Weight Loss Drugs Revenue Market Share by Countries (2013-2017) Table North America Weight Loss Drugs Sales by Type (2013-2017) Table North America Weight Loss Drugs Sales Share by Type (2013-2017) Table North America Weight Loss Drugs Revenue by Type (2013-2017) Table North America Weight Loss Drugs Revenue Share by Type (2013-2017) Table North America Weight Loss Drugs Sales by Downstream Industry (2013-2017) Table North America Weight Loss Drugs Sales Share by Downstream Industry (2013-2017) Table Europe Weight Loss Drugs Sales by Countries (2013-2017) Table Europe Weight Loss Drugs Sales Share by Countries (2013-2017) Table Europe Weight Loss Drugs Revenue by Countries (2013-2017) Table Europe Weight Loss Drugs Revenue Market Share by Countries (2013-2017) Table Europe Weight Loss Drugs Sales by Type (2013-2017) Table Europe Weight Loss Drugs Sales Share by Type (2013-2017) Table Europe Weight Loss Drugs Revenue by Type (2013-2017) Table Europe Weight Loss Drugs Revenue Share by Type (2013-2017) Table Europe Weight Loss Drugs Sales by Downstream Industry (2013-2017) Table Europe Weight Loss Drugs Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Weight Loss Drugs Sales by Countries (2013-2017) Table Asia Pacific Weight Loss Drugs Sales Share by Countries (2013-2017) Table Asia Pacific Weight Loss Drugs Revenue by Countries (2013-2017) Table Asia Pacific Weight Loss Drugs Revenue Market Share by Countries (2013-2017) Table Asia Pacific Weight Loss Drugs Sales by Type (2013-2017) Table Asia Pacific Weight Loss Drugs Sales Share by Type (2013-2017) Table Asia Pacific Weight Loss Drugs Revenue by Type (2013-2017) Table Asia Pacific Weight Loss Drugs Revenue Share by Type (2013-2017) Table Asia Pacific Weight Loss Drugs Sales by Downstream Industry (2013-2017) Table Asia Pacific Weight Loss Drugs Sales Share by Downstream Industry (2013-2017) Table Latin America Weight Loss Drugs Sales by Countries (2013-2017) Table Latin America Weight Loss Drugs Sales Share by Countries (2013-2017) Table Latin America Weight Loss Drugs Revenue by Countries (2013-2017) Table Latin America Weight Loss Drugs Revenue Market Share by Countries (2013-2017) Table Latin America Weight Loss Drugs Sales by Type (2013-2017) Table Latin America Weight Loss Drugs Sales Share by Type (2013-2017) Table Latin America Weight Loss Drugs Revenue by Type (2013-2017) Table Latin America Weight Loss Drugs Revenue Share by Type (2013-2017) Table Latin America Weight Loss Drugs Sales by Downstream Industry (2013-2017) Table Latin America Weight Loss Drugs Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Weight Loss Drugs Sales by Regions (2013-2017) Table Middle East and Africa Weight Loss Drugs Sales Share by Regions (2013-2017) Table Middle East and Africa Weight Loss Drugs Revenue by Regions (2013-2017) Table Middle East and Africa Weight Loss Drugs Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Weight Loss Drugs Sales by Type (2013-2017) Table Middle East and Africa Weight Loss Drugs Sales Share by Type (2013-2017) Table Middle East and Africa Weight Loss Drugs Revenue by Type (2013-2017) Table Middle East and Africa Weight Loss Drugs Revenue Share by Type (2013-2017) Table Middle East and Africa Weight Loss Drugs Sales by Downstream Industry (2013-2017) Table Middle East and Africa Weight Loss Drugs Sales Share by Downstream Industry (2013-2017) Table Production Volume of Weight Loss Drugs by Major Manufacturers 2013-2017 Table Production Value of Weight Loss Drugs by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Weight Loss Drugs Major Manufacturer Table Employees and Revenue Level of Weight Loss Drugs Major Manufacturer Table Representative Weight Loss Drugs Product One of Roche Table Representative Weight Loss Drugs Product Two of Roche Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Roche 2013-2017 Table Representative Weight Loss Drugs Product One of GSK group Table Representative Weight Loss Drugs Product Two of GSK group Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of GSK group 2013-2017 Table Representative Weight Loss Drugs Product One of Teva Table Representative Weight Loss Drugs Product Two of Teva Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Teva 2013-2017 Table Representative Weight Loss Drugs Product One of Sandoz(Novartis) Table Representative Weight Loss Drugs Product Two of Sandoz(Novartis) Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Sandoz(Novartis) 2013-2017 Table Representative Weight Loss Drugs Product One of STADA-VN J.V.Co., Ltd Table Representative Weight Loss Drugs Product Two of STADA-VN J.V.Co., Ltd Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of STADA-VN J.V.Co., Ltd 2013-2017 Table Representative Weight Loss Drugs Product One of Hexal AG Table Representative Weight Loss Drugs Product Two of Hexal AG Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hexal AG 2013-2017 Table Representative Weight Loss Drugs Product One of National Company For Pharmaceutical Industry Table Representative Weight Loss Drugs Product Two of National Company For Pharmaceutical Industry Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of National Company For Pharmaceutical Industry 2013-2017 Table Representative Weight Loss Drugs Product One of Lunan Pharmaceutical Group Corporation Table Representative Weight Loss Drugs Product Two of Lunan Pharmaceutical Group Corporation Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Lunan Pharmaceutical Group Corporation 2013-2017 Table Representative Weight Loss Drugs Product One of Zein Pharmaceutical Table Representative Weight Loss Drugs Product Two of Zein Pharmaceutical Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Zein Pharmaceutical 2013-2017 Table Representative Weight Loss Drugs Product One of Hisun Table Representative Weight Loss Drugs Product Two of Hisun Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hisun 2013-2017 Table Representative Weight Loss Drugs Product One of Taj Pharmaceuticals Ltd Table Representative Weight Loss Drugs Product Two of Taj Pharmaceuticals Ltd Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Ltd 2013-2017 Table Representative Weight Loss Drugs Product One of Kabir Life Sciences & Research Table Representative Weight Loss Drugs Product Two of Kabir Life Sciences & Research Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Kabir Life Sciences & Research 2013-2017 Table Representative Weight Loss Drugs Product One of Dm Pharma Table Representative Weight Loss Drugs Product Two of Dm Pharma Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Dm Pharma 2013-2017 Table Representative Weight Loss Drugs Product One of China Zhongshan Pharm Table Representative Weight Loss Drugs Product Two of China Zhongshan Pharm Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of China Zhongshan Pharm 2013-2017